MACK - MERRIMACK PHARMACEUTICALS INC

QQQ $ 435.98 $ 8.58 (2.01 %)

DIA $ 386.87 $ 4.54 (1.19 %)

SPY $ 511.25 $ 6.26 (1.24 %)

TLT $ 89.88 $ 0.90 (1.01 %)

GLD $ 212.97 $ -0.17 (-0.08 %)

Previous Close

$ 15

Open

$ 15.00

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 15.00 - $ 15.02

52 Week Range

$ 11.53 - $ 15.89

Volume

187,592

Average Volume

Market Cap

214.49M

Beta (5Y Monthly)

$ 1.61

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-07-2024	12-31-2023	10-K
2	11-02-2023	09-30-2023	10-Q
3	08-03-2023	06-30-2023	10-Q
4	05-04-2023	03-31-2023	10-Q
5	03-09-2023	12-31-2022	10-K
6	11-03-2022	09-30-2022	10-Q
7	08-04-2022	06-30-2022	10-Q
8	05-05-2022	03-31-2022	10-Q
9	03-09-2022	12-31-2021	10-K
10	11-04-2021	09-30-2021	10-Q
11	08-05-2021	06-30-2021	10-Q
12	05-06-2021	03-31-2021	10-Q
13	03-10-2021	12-31-2020	10-K
14	11-04-2020	09-30-2020	10-Q
15	08-07-2020	06-30-2020	10-Q
16	05-07-2020	03-31-2020	10-Q
17	03-12-2020	12-31-2019	10-K
18	11-12-2019	09-30-2019	10-Q
19	07-17-2019	06-30-2019	10-Q
20	05-10-2019	03-31-2019	10-Q
21	03-06-2019	12-31-2018	10-K
22	11-07-2018	09-30-2018	10-Q
23	08-07-2018	06-30-2018	10-Q
24	05-08-2018	03-31-2018	10-Q
25	03-12-2018	12-31-2017	10-K
26	11-08-2017	09-30-2017	10-Q
27	08-09-2017	06-30-2017	10-Q
28	05-10-2017	03-31-2017	10-Q
29	03-01-2017	12-31-2016	10-K
30	11-09-2016	09-30-2016	10-Q
31	08-04-2016	06-30-2016	10-Q
32	05-02-2016	03-31-2016	10-Q
33	02-26-2016	12-31-2015	10-K
34	11-09-2015	09-30-2015	10-Q
35	08-10-2015	06-30-2015	10-Q
36	05-07-2015	03-31-2015	10-Q
37	02-27-2015	12-31-2014	10-K
38	11-10-2014	09-30-2014	10-Q
39	08-11-2014	06-30-2014	10-Q
40	05-06-2014	03-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Merrimack Pharmaceuticals To Voluntary Del...
04/30/2024 21:40:17

Merrimack Secures $225M Milestone Payment ...
03/27/2024 20:34:00

The company has received a $225 million payment which was due from Ipsen, S.A. as a result of its receipt of approval from the ...

Merrimack FY23 EPS $(0.08) Per Basic Share
03/07/2024 21:34:01

Ipsen's Onivyde Regimen, A Potential New S...
02/13/2024 21:50:10

Approval based on Phase III NAPOLI 3 clinical trial in which Onivyde® regimen (NALIRIFOX) demonstrated statistically significan...

Merrimack Management Estimates That The Ag...
02/13/2024 21:25:26

Merrimack Says Ipsen's FDA Approval Of Oni...
02/13/2024 21:24:36

BZ NOTE: Merrimack Pharmaceuticals, As Par...
02/13/2024 18:31:16

FDA Approves Irinotecan Liposome For First...
02/13/2024 18:19:13

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-irinotecan-liposome-first-line-treatment-metastatic...

$2M Bet On Ford? Check Out These 4 Stocks ...
12/12/2023 11:46:14

Although U.S. stocks closed higher on Monday, there were a few notable insider trades.

Merrimack Pharmaceuticals Q3 EPS $(0.02) U...
11/02/2023 21:45:35

Merrimack Pharmaceuticals (NASDAQ:MACK) reported quarterly losses of $(0.02) per share. This is a 33.33 percent increase over l...

Merrimack Pharmaceuticals Q2 EPS $(0.03) U...
08/03/2023 21:23:14

Merrimack Pharmaceuticals (NASDAQ:MACK) reported quarterly losses of $(0.03) per share. This is a 25 percent increase over loss...

Merrimack Pharmaceuticals Q1 EPS $(0.02) D...
05/04/2023 21:16:30

Merrimack Pharmaceuticals (NASDAQ:MACK) reported quarterly losses of $(0.02) per share. This is a 100 percent decrease over los...

why-jounce-therapeutics-shares-are-trading-higher-by-around-37-here-are-20-stocks-moving-premarket

Why Jounce Therapeutics Shares Are Trading...
03/15/2023 12:39:36

Gainers

luna-innovations-guess-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session

Luna Innovations, Guess? And Other Big Sto...
03/15/2023 11:21:54

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Merrimack Pharmaceuticals FY22 EPS (0.11) ...
03/09/2023 21:43:06

Full Year 2022 Financial Results Merrimack reported net loss of $1.5 million for the year ended December 31, 2022, or $0.11 pe...

3-stocks-insiders-are-buying-triumph-financial-and-more

3 Stocks Insiders Are Buying: Triumph Fina...
02/01/2023 11:40:51

Although US stocks closed higher on Tuesday, there were a few notable insider trades.

26m-bet-on-this-energy-stock-check-out-these-3-stocks-insiders-are-buying

$2.6M Bet On This Energy Stock? Check Out ...
01/18/2023 11:25:33

Although US stocks closed mostly lower on Tuesday, there were a few notable insider trades.

insiders-buying-heska-b-riley-financial-and-2-other-stocks

Insiders Buying Heska, B. Riley Financial ...
01/10/2023 11:51:53

Although US stocks closed mixed on Monday, there were a few notable insider trades.

14-million-bet-on-joint-corp-check-out-these-3-stocks-insiders-are-buying

$1.4 Million Bet On Joint Corp? Check Out ...
01/04/2023 11:39:27

Although US stocks closed lower on Tuesday, there were a few notable insider trades.

why-merrimack-pharmaceuticals-shares-jumped-around-213-here-are-114-biggest-movers-from-yesterday

Why Merrimack Pharmaceuticals Shares Jumpe...
11/10/2022 10:12:56

Gainers